FTSE headlines include Reckitt Benckiser cutting its FY outlook after Q3 was affected by challenging markets. Rio Tinto reached $36.4m, settlement with FCA in relation to RTCM impairment; SEC civil complaint alleges fraud. AstraZeneca gets FDA priority review for Lynparza for metastatic breast cancer. BHP Billiton reiterates FY production and unit cost guidance.